Status:
RECRUITING
Prospective Study for the Prognostic and Predictive Role of Circulating Tumor Cells in Patients With Oropharyngeal Squamous Cell Carcinoma: CTCO (Circulating Tumor Cells in the Oropharynx)
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Circulating Tumor Cell
Oropharyngeal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Head and neck cancers (HNSCC) are primarily squamous cell cancers represented by tumors of the upper aerodigestive tract. Locally advanced stages (stages III and IV) account for 50 to 70% of all prese...
Eligibility Criteria
Inclusion
- Over 18 years of age
- Squamous cell carcinoma proven on biopsy
- Oropharyngeal location
- Curative treatment by Surgery followed by radiotherapy (chemotherapy) Or Radiochemotherapy Or Induction chemotherapy (+/- surgery) + radiotherapy
- Did not object to their participation in the study
Exclusion
- Carcinoma of the nasopharynx, larynx, oral cavity or hypopharynx
- Pregnant or breastfeeding woman
Key Trial Info
Start Date :
June 23 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04696744
Start Date
June 23 2021
End Date
June 1 2027
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service ORL Chirurgie Cervico-faciale (Pr Philippe CERUSE)
Lyon, France, 69004